|
🐜
|
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
108 auth.
R. Ella,
Siddarth Reddy,
W. Blackwelder,
V. Potdar,
P. Yadav,
V. Sarangi,
V. K. Aileni,
S. Kanungo,
S. Rai,
P. Reddy,
S. Verma,
C. Singh,
S. Redkar,
S. Mohapatra,
A. Pandey,
...
P. Ranganadin,
R. Gumashta,
M. Multani,
Shameem G. Mohammad,
P. Bhatt,
Laxmi Kumari,
G. Sapkal,
N. Gupta,
P. Abraham,
S. Panda,
S. Prasad,
B. Bhargava,
K. Ella,
K. M. Vadrevu,
P. Aggarwal,
V. Aglawe,
A. Ali,
N. Anand,
N. Awad,
V. Bafna,
G. Balasubramaniyam,
A. Bandkar,
P. Basha,
V. Bharge,
A. Bhate,
S. Bhate,
V. Bhavani,
R. Bhosale,
D. Chalapathy,
C. Chaubal,
D. Chaudhary,
A. Chavan,
P. Desai,
D. Dhodi,
S. Dutta,
R. Garg,
K. Garg,
M. George,
P. Goyal,
R. Guleria,
S. Gupta,
M. Jain,
M. Jain,
S. Jindal,
M. Kalra,
S. Kant,
P. Khosla,
P. Kulkarni,
P Arun Kumar,
Y. Kumar,
A. Majumdar,
P. Meshram,
V. Mishra,
S. Mohanty,
J. Nair,
S. Pandey,
S. K. Panigrahi,
B. Patil,
V. Patil,
P. Rahate,
V. Raj,
S. Ramanand,
K. Rami,
B. Ramraj,
S. Rane,
E. Rao,
N. Rao,
R. Raphael,
G. Reddy,
V. Redkar,
S. Redkar,
A. Sachdeva,
J. Saha,
J. Sahoo,
P. Sampath,
A. Savith,
M. Shah,
L. Shanmugam,
R. Sharma,
P. Sharma,
Devender Kumar Sharma,
A. Singh,
J. Singh,
P. Singh,
S. Sivaprakasam,
S. Subramaniam,
D. Sudheer,
S. Tandon,
M. Tariq,
V. Tripathi,
M. Vable,
R. Verma,
S. Waghmare
|
7 |
2021 |
7
🐜
|
|
🐜
|
A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL‐1401O vs. EU‐trastuzumab and US‐trastuzumab
12 auth.
C. Waller,
Apinya Vutikullird,
T. Lawrence,
Andrew R Shaw,
M. Liu,
Mark Baczkowski,
...
Rajiv Sharma,
Abhijit Barve,
P. Goyal,
Charles Donnelly,
Nilanjan Sengupta,
E. Pennella
|
4 |
2018 |
4
🐜
|
|
🦁
|
Physicochemical and functional characterization of MYL-1501D, a proposed biosimilar to insulin glargine
25 auth.
P. Goyal,
Harish Pai,
P. Kodali,
Bhavesh Vats,
N. Vajpai,
Shankara Annegowda,
Krishnappa Mane,
Shamini Mohan,
S. Saxena,
Anil Bangalore Veerabhadraia,
Milee Palande,
Preethy S.E. Nair,
D. C. More,
Umamaheshwara Rao Karudumpa,
Kunala Jyothirmai,
...
Adroha Bhattacharya,
Frida Almeida,
Santosh Gulab Khyade,
Shankar Gouda,
Daniel J. Ranayhossaini,
Praveen Reddy Moole,
Jeffrey P. Smith,
Abhijit Barve,
R. Melarkode,
Rajesh Ullanat
|
2 |
2021 |
2
🦁
|
|
🦁
|
Analytical similarity assessment of MYL-1402O to reference Bevacizumab
25 auth.
P. Goyal,
Bhavesh Vats,
M. Subbarao,
Chethan Gejjalagere Honnappa,
Pradeep G. Kabadi,
S. Rohil,
Arnab Bera,
Gaurav R Mehta,
Harish Pai,
Laxmi Adhikari,
R. Tagore,
Shulagna Sharma,
Roopa Venkatachala,
P. Nair,
Shankara Annegowda,
...
Abhilashi Sahu,
Sneha Trivedi,
N. Shastri,
Y. Gokhale,
R.S. Thomas,
A. Thakur,
Deepa Mohan,
Umamaheshwara Rao K,
R. Melarkode,
Rajesh Ullanat
|
2 |
2021 |
2
🦁
|
|
🐜
|
Characterization and similarity assessment of a pegfilgrastim biosimilar MYL-1401H.
11 auth.
P. K. Sankaran,
D. Palanivelu,
Reshmi Nair,
Preethy S.E. Nair,
Harish Pai,
Praveen Reddy Moole,
...
Rajesh Ullanat,
P. Goyal,
Daniel J. Ranayhossaini,
Jeffrey Smith,
G. Ranganna
|
1 |
2018 |
1
🐜
|
|
🐜
|
Evaluation of physicochemical and biological properties of nonreconstituted MYL-1401O vials, reconstituted MYL-1401O suspension in vial, and diluted MYL-1401O suspension in infusion bags (0.9% saline) for extended duration
17 auth.
Bhavesh Vats,
P. Goyal,
Z. Mathew,
Ranendu Ghosh,
Moram Narendra Babu,
R. Jadav,
Arya M. Nair,
M. Subbarao,
Arnab Bera,
Kirthi Prakash Sadasivappa,
...
Pradeep G. Kabadi,
Anindya Sarkar,
Chethan Gejjalagere Honnappa,
Uma Sankar Patnaik,
Ankita Singh,
Anusha Valiya Parambath,
Rajesh Ullanat
|
1 |
2021 |
1
🐜
|
|
🦁
|
Physicochemical and functional characterization of trastuzumab-dkst, a trastuzumab biosimilar.
20 auth.
P. Goyal,
J. Iyer,
L. Adhikary,
Bhavesh Vats,
Pradeep G. Kabadi,
Harish Pai,
Daniel Ranayhossaini,
Shankar Gouda,
M. Subbarao,
G. Mehta,
...
A. Saha,
Arnab Bera,
Abhilashi Sahu,
Maninder Kaur,
Ankita Singh,
A. Marwah,
Praveen Kumar Reddy Moole,
Jeffrey Smith,
R. Melarkode,
Rajesh Ullanat
|
0 |
2021 |
0
🦁
|
